Photocure ASA

Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2023 financial results

Oslo, Norway, 19 February 2024: Photocure ASA (Photocure, PHO: OSE) will

announce the fourth quarter and preliminary full year 2023 financial results on

Wednesday 21 February 2024 at 08:00 CET and will present a live webcast at 14:00

CET the same day.

The quarterly report and presentation will be published at 08:00 CET and will be

publicly available at www.photocure.com.

The investor presentation will be streamed live and be hosted by Dan Schneider,

CEO and Erik Dahl, CFO. The presentation will be held in English and questions

can be submitted throughout the event. The presentation is scheduled to conclude

at 14:45 CET.

The streaming event is available through

https://channel.royalcast.com/landingpage/hegnarmedia/20240221_5/ (https://eur01.

safelinks.protection.outlook.com/?url=https%3A%2F%2Fchannel.royalcast.com%2Flandi

ngpage%2Fhegnarmedia%2F20240221_5%2F&data=05%7C02%7CTH%40photocure.no%7C3927bf824

64f41ac7d5308dc30b85f71%7C0986794f1d6f488980bd853c0715d3c1%7C0%7C0%7C638438815640

946018%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haW

wiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=vXoPi76on8Das0VeVb8BAkEiYBgnwtw0L9d3rf%2F66BY

%3D&reserved=0)

For further information, please contact:

Photocure

Erik Dahl

CFO

Tel: +47 45055000

David Moskowitz

Vice President, Investor Relations

Tel: +1 202 280 0888

Media and IR enquiries:

Geir Bjørlo

Corporate Communications (Norway)

Tel: +47 91540000

About Photocure

Photocure: The Bladder Cancer Company delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, making

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us at

www.photocure.com, www.hexvix.com, www.cysview.com

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

AI Terminal